Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK1 | P06493 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | IDO1 | P14902 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | NOS3 | P29474 | 1/20 | 0.31 |
| ▸ | NOS2 | P35228 | 1/20 | 0.31 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.30 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18520396 | 0.86 | ALDH1A1 (0.41) | CDK1ALDH1A1ALOX15TSHRLMNA | |
| SCHEMBL19754271 | 0.79 | IDO1 (0.41) | CDK1ALDH1A1ALOX15TSHRLMNA | |
| SCHEMBL3847571 | 0.79 | ALDH1A1 (0.35) | ALDH1A1ALOX15TSHRLMNAKDM4E | |
| SCHEMBL19984155 | 0.79 | PDE10A (0.38) | CDK1ALDH1A1ALOX15TSHRLMNA | |
| SCHEMBL30696400 | 0.77 | LMNA (0.52) | CDK1ALDH1A1ALOX15TSHRLMNA | |
| SCHEMBL11775855 | 0.77 | LMNA (0.52) | CDK1ALDH1A1ALOX15TSHRLMNA | |
| SCHEMBL18153980 | 0.75 | CDK1 (0.33) | CDK1ALDH1A1ALOX15TSHRLMNA | |
| SCHEMBL18913381 | 0.75 | CDK1 (0.33) | CDK1ALDH1A1ALOX15TSHRLMNA | |
| SCHEMBL14864520 | 0.75 | PDE10A (0.41) | CDK1ALDH1A1ALOX15TSHRLMNA | |
| SCHEMBL3444583 | 0.72 | ALDH1A1 (0.39) | CDK1ALDH1A1ALOX15TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4676926-A1 | BICYCLIC HETEROARYL COMPOUNDS FOR USE AS GPR35 MODULATORS | ThirtyFiveBio Limited (GB) | 2026-01-14 | — | — | EP | disclosed |
| WO-2024184650-A1 | BICYCLIC HETEROARYL COMPOUNDS FOR USE AS GPR35 MODULATORS. | ThirtyFiveBio Limited (GB) | 2024-09-12 | — | — | WO | disclosed |
| WO-2020186220-A1 | COMPOUNDS AS INHIBITORS OF MACROPHAGE MIGRATION INHIBITORY FACTOR | IMMUNOPHAGE BIOMEDICAL CO., LTD. (CN) | 2020-09-17 | — | — | WO | disclosed |
| US-6919455-B2 | Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof | MITSUBISHI CHEMICAL CORPORATION (JP) | 2005-07-19 | — | — | US | disclosed |
| CN-1160355-C | Purine derivative dihydrate, drug containing the compound as active ingredient, and intermediate for production thereof | ������ѧ��ʽ���� | 2004-08-04 | — | — | CN | disclosed |
| US-20040077665-A1 | Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof | MITSUBISHI CHEMICAL CORPORATION (JP) | 2004-04-22 | — | — | US | disclosed |
| US-6660745-B1 | Phosphodiesterase inhibitors; treatment of asthma, chronic obstructive pulmonary disease, inflammatory disorders | MITSUBISHI CHEMICAL CORPORATION (JP) | 2003-12-09 | — | — | US | disclosed |
| EP-1178046-B1 | PURINE DERIVATIVE DIHYDRATE, DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT AND INTERMEDIATE IN THE PRODUCTION THEREOF | MITSUBISHI CHEM CORP (JP) | 2003-11-19 | — | — | EP | disclosed |
| CN-1350535-A | Purine derivative dihydrate, drug containing the compound as active ingredient, and intermediate for production thereof | MITSUBISHI CHEM CORP (JP) | 2002-05-22 | — | — | CN | disclosed |
| EP-1178046-A1 | PURINE DERIVATIVE DIHYDRATE, DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT AND INTERMEDIATE IN THE PRODUCTION THEREOF | MITSUBISHI CHEMICAL CORPORATION (JP) | 2002-02-06 | — | — | EP | disclosed |
| US-5332744-A | Hypotensive, congestive heart failure, intraocular pressure | MERCK & CO., INC. (US) | 1994-07-26 | — | — | US | disclosed |
| US-5177074-A | Heterocyclic nitrogen compounds used to treat hypertension, cognitive dysfunction, anxiety or depression | MERCK & CO., INC. (US) | 1993-01-05 | — | — | US | disclosed |
| EP-0513979-A1 | Angiotensin II antagonists incorporating a substituted thiophene or furan | MERCK & CO. INC. (US) | 1992-11-19 | — | — | EP | disclosed |
| US-5157026-A | Oxo-purines as angiotensin II antagonists | MERCK & CO., INC. (US) | 1992-10-20 | — | — | US | disclosed |
| EP-0508723-A1 | Angiotensin II antagonists incorporating an indole or dihydroindole | MERCK & CO. INC. (US) | 1992-10-14 | — | — | EP | disclosed |
| US-5151435-A | Hypotensive agents, glaucoma and cognition activators | MERCK & CO., INC. (US) | 1992-09-29 | — | — | US | disclosed |
| US-5102880-A | Biphenyl imidazotriazine derivatives; Hypotensive and cardiotonic agents | MERCK & CO., INC. (US) | 1992-04-07 | — | — | US | disclosed |
| EP-0400974-A2 | Substituted imidazo-fused 6-membered heterocycles as angiotensin II antagonists | MERCK & CO. INC. (US) | 1990-12-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040077665-A1 | Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof | DPYD, NUDT1, PNP | CDK1 1853/4885ALDH1A1 323/4885ALOX15 830/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.